About
EnCompass Technologies
Our Vision
To eliminate brain injury, including stroke, due to embolic debris during cardiac procedures.
Our Mission
To benefit patients by advancing effective, efficient, and safe embolic filtration across the spectrum of cardiac procedures.
Our Leadership
Executive Team
George Wallace
Founder and CEO
Over 40 years medical device experience. Has built, financed, and exited multiple cardio- & neurovascular companies.
Mike Jones
Founder and VP of R&D
35 years medical device experience in product development & manufacturing across 5+ cardio- & neurovascular companies. 106 medical device patents.
Carl Swindle
VP R&D and Operations
35 years medical device experience in R&D, business development, operations, clinical and marketing. Heart disease and neurology expertise.
Kathleen Calderon
Senior Director of Clinical
Over 20 years medical device experience in clinical trial management at small and large companies.
Jeff Weinrich
VP Therapy Solutions
Over 30 years med device commercial sales leadership experience. CV surgery, interventional cardiology, PV & neuro intervention and electrophysiology expertise.
Jen Epp
VP Marketing
Over 20 yrs marketing and strategy experience, primarily in med device across early to commercial stage companies.
Lauren Baker, ME, PhD
Regulatory & Clinical
Over 30 years medical device experience in regulatory & clinical. CEO of Insight Medical Consulting.
Melissa Fusari, M.D.
Physician Proctor
Cardiovascular Surgeon trained in Interventional. University of Milan 2001-12. Edwards Life Sciences. (Physician Proctor Sapien & TAVR) 2012-25.
Contractors
Insight Medical Constulting (CRO); Avania US/AUS (CRO); Dr. May Nour, Neuromerit (Core Lab); Oculus Imaging (MRI Core Lab)
Board of Directors
George Wallace
CEO & Director
Bill Starling
Director
Chris Martin
Director
Steve Gex
Director
Medical Advisors
Tamim Nazif, MD
Interventional Cardiologist NY
Presbyterian/Columbia Univ, NYC
Isaac George, MD
Cardiac Surgeon NY Presbyterian/Columbia Univ, NYC
Steve Yakubov, MD
Interventional Cardiologist
Riverside
Methodist Hosp, Columbus
Jim Hermiller, MD
Interventional Cardiologist
St. Vincent’s Hospital, Indianapolis
Ulrich Schaefer, MD
Interventional Cardiologist
Hospital Bonn, Germany
May Nour, MD, PhD
Vascular & Interventional
Neurologist
UCLA
Newsroom
Press Release
May 23, 2023
World's First Use of EnCompass Medical Device to Protect Against Brain Injury Achieved at the Israeli-Georgian Medical Research Clinic, Tbilisi, Georgia
Press Release
September 27, 2023
EnCompass receives FDA conditional IDE approval to commence a US pilot study of its F2 cerebral embolic protection (CEP) system in patients...
Resources
Jacc: February 2017
Lansky et al
Neurologic Endpoints for CV Clinical Trials
New York Valves: June 2024
Lansky
Modern Era Clinical Trial Strategies for Cerebral Embolic Protection
Jacc: August 2024
Lansky et al
Clinical Significance of DW-MRI Lesions After TAVR
JSCAI: March 2025
George et al
FIH Experience with EnCompass F2 (12 Patients)
New York Valves: June 2025
Gooley et al
FIH Experience with EnCompass F2 (49 Patients)
Cardiovasc Eng Technol: October 2025
Ghovvati et al
